Score Breakdown
Offering Ability
60
Cash Runway
95
Float Risk
12
Warrant Exposure
15
Convertible Debt
40
Dilution Forecast
⛈️
Warning
High probability of dilution event
model est. 53%
🔄 Reverse Split
model est. 70%
• 50-day avg $0.78 below $1 exchange minimum
• Only 0 months cash — financial pressure
💰 Capital Raise
model 55%
• Critical: only 0.4 months cash remaining
📉 Score Deterioration
model 10%
• Score in HIGH risk zone (65/100)
Market Data
Market Cap$8.28M
Shares Outstanding11.03M
Float9.97M
Cash$218.0K
Debt$1.26M
Short InterestN/A
Institutional Holdings
5 institutional holders · 4.1K shares
#1
OSAIC HOLDINGS, INC.
3.6K shares
#2
Bangor Savings Bank
266 shares
#3
VSM Wealth Advisory, LLC
120 shares
+ 2 more holders Sign up free to view →
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest47.0K
Days to Cover2.5
% of Float0.5%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2025-12-31
xbrl
XBRL CONVERTIBLE
2013-12-31
8-K
8K EVENT
2026-02-27
8-K
8K EVENT
2026-02-13
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual BCLI Dilution Snapshot
Brainstorm Cell Therapeutics Inc. (BCLI) has a DilutionScore of 65/100, rated High dilution risk. Score date: August 28, 2026.
- Stored outstanding warrants: 250,000.
- Recent SEC activity tracked for BCLI: 8-K on 2026-02-27; 8-K on 2026-02-13; xbrl on 2025-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — HIGH Risk
Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles: